“Angiotensin-Converting Enzyme Inhibitor Angiotensin II Receptor Blocker in COVID-19: A Double-Edged Sword or a Myth”. 2020. Nepalese Medical Journal 3 (1): 309-12. https://doi.org/10.3126/nmj.v3i1.28726.